Delcath Systems Inc (NASDAQ:DCTH) Q1 2024 Results Earnings Conference Call May 14, 2024 8:30 AM ET

Company Participants

David Hoffman - General Counsel, Corporate Secretary and Chief Compliance Officer
Gerard Michel - Chief Executive Officer
Sandra Pennell - Senior Vice President of Finance
Kevin Muir - General Manager, Interventional Oncology

Conference Call Participants

William Maughan - Canaccord Genuity LLC
Marie Thibault - BTIG
Yale Jen - Laidlaw & Company
Sean Lee - H.C. Wainwright & Co., LLC

Operator

Good day. And welcome to the Delcath Systems Reports First Quarter Fiscal Year 2024 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please note that this event is being recorded.

I would now like to turn the conference over to David Hoffman, Delcath General Counsel. Please go ahead.

David Hoffman

Thank you. And once again, welcome to Delcath Systems 2024 first quarter earnings and business highlights call.

With me on the call are Gerard Michel, Chief Executive Officer; Sandra Pennell, Senior Vice President of Finance; Kevin Muir, General Manager, Interventional Oncology; Vojo Vukovic, Chief Medical Officer; and Martha Rook, Chief Operating Officer.

I'd like to begin the call by reading the Safe Harbor statement. This statement is made pursuant to the safe harbor for forward-looking statements described in the Private Securities Litigation Reform Act of 1995. All statements made on this call, with the exception of historical facts, may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

Although the company believes that expectations and assumptions reflected in these forward-looking statements are reasonable, it makes no assurance that such expectations will prove to have been correct. Actual results may differ materially from those expressed or implied in forward-looking statements due to various risks and uncertainties.

For a discussion of such risks and uncertainties, which could cause actual results to differ from those expressed or implied in the forward-looking statements, please see risk factors detailed in the company's annual report on Form 10-K, those contained in subsequently filed quarterly reports on Form 10-Q as well as in other reports that the company files from time-to-time with the Securities and Exchange Commission.

Any forward-looking statements included in this call are made only as of the date of this call. We do not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent knowledge, events or circumstances.